K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: A comparison before and after eradication in patients with chronic gastritis and gastric cancer

Journal of Clinical Pathology

Volumn 60, Issue 8, 2007, Pages 921-926

  Watari, J ^a   Tanaka, A ^a   Tanabe, H ^a   Sato, R ^a   Moriichi, K ^a   Zaky, A ^a   Okamoto, K ^a   Maemoto, A ^a   Fujiya, M ^a   Ashida, T ^a   Das, K M ^b   Kohgo, Y ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; MONOCLONAL ANTIBODY KI 67;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL KINETICS; CELL PROLIFERATION; CHRONIC GASTRITIS; CODON; CONTROLLED STUDY; DNA SEQUENCE; ERADICATION THERAPY; GENE MUTATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE METAPLASIA; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MONOCYTE; NICK END LABELING; ONCOGENE K RAS; PRECANCER; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CANCER;

APOPTOSIS; CELL DIVISION; CHRONIC DISEASE; CODON; GASTRITIS; GENES, RAS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METAPLASIA; MUTATION; NEUTROPHILS; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; STOMACH; STOMACH NEOPLASMS;

EID: 34547776913     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.041939     Document Type: Article

References (41)

1. Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990;66:2569-74.
2. Sipponen P, Hyvarinen H. Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol 1993;196(Suppl):3-6.
3. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori. Lyon: IARC, 1994;61:177-240.
4. Graham DY. Helicobacter pylori infection is the primary cause of gastric cancer. J Gastroenterology 2000;35(Suppl 12):90-7.
5. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
6. Correa P, Shiao YH. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 1994;54:1941s-3s.
7. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19:S37-43.
8. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-60.
9. Filipe MI, Munoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994;57:324-9.
10. Miehlke S, Hackelsberger A, Meining A, et al. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori. Br J Cancer 1998;78:263-6.
11. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
12. Soh K, Yanagisawa A, Hiratsuka H, et al. Variation in K-ras codon 12 point mutation rate with histological atypia within individual colorectal tumors. Jpn J Cancer Res 1993;84:388-93.
13. Cooper GM. Guanine nucleotide binding proteins. In: Cooper GM, ed. Oncogenes, 2nd edn. Sudbury, MA: Jones and Bartlett Publishers, 1995:222-42.
14. Tahara E. Molecular mechanism of stomach carcinogenesis. Cancer Res Clin Oncol 1993;119:265-72.
15. Arber N, Shapira I, Ratan J, et al. Activation of c-K-ras mutations in human gastrointestinal tumors. Gastroenterology 2000;118:1045-50.
16. Hiyama T, Haruma K, Kitadai Y, et al. K-ras mutation in Helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. Int J Cancer 2002;97:562-6.
17. Yanagisawa A, Ohtake K, Ohashi K, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993;53:953-6.
18. Chaubert P, Benhattar J, Saraga E, et al. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol 1994;144:767-75.
19. Gong C, Mera R, Bravo JC, et al. KRAS mutations predict progression of preneoplastic gastric lesions. Cancer Epidemiol Biomark Prev 1999;8:167-71.
20. Moss SF, Calam J, Agarwal B, et al. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996;38:498-501.
21. Wagner S, Beil W, Westermann J, et al. Regulation of gastric epithelial cell growth by Helicobacter pylori: evidence for a major role of apoptosis. Gastroenterology 1997;113:1836-47.
22. Jones NL, Shannon PT, Cutz E, et al. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 1997;151:1695-703.
23. Hoshi T, Sasano H, Kato K, et al. Cell damage and proliferation in human gastric mucosa infected by Helicobacter pylori - a comparison before and after H pylori eradication in eradication in non-atrophic gastritis. Hum Pathol 1999;30:1412-17.
24. Leung WK, Yu J, To KF, et al. Apoptosis and proliferation in Helicobacter pylori-associated gastric intestinal metaplasia. Aliment Pharmacol Ther 2001;15:1467-72.
25. Levi S, Urbano-Ispizua A, Gill R, et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991;51:3497-502.
26. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1997;74:5463- 7.
27. Watari J, Saitoh Y, Obara T, et al. Natural history of colorectal nonpolypoid adenomas: a prospective colonoscopic study and relation with cell kinetics and K-ras mutations. Am J Gastroenterol 2002;97:2109-15.
28. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
29. Kawachi T, Kogure K, Tanaka N, et al. Studies of intestinal metaplasia in the gastric mucosa by detection of disaccharidases with "Tes-Tape". J Natl Cancer Inst 1974;53:19-30.
30. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
31. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarker Prev 1997;6:639-42.
32. Wong BC-Y, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187-94.
33. Lee KH, Lee JS, Suh C, et al. Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases. Cancer 1995;75:2794-801.
34. Bonner RF, Emmert-Buck M, Cole K, et al. Laser capture microdissection: molecular analysis of tissue. Science 1997;278:1481-3.
35. Dillon D, Zheng K, Costa J. Rapid, efficient genotyping of clinical tumor samples by laser-capture microdissection/PCR/SSCP. Exp Mol Pathol 2001;70:195-200.
36. van der Hulst RW, van der Ende A, Dekker FW, et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: A prospective 1-year follow-up study. Gastroenterology 1997;113:25- 30.
37. Witteman EM, Mravunac M, Becx MJ, et al. Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori. J Clin Pathol 1995;48:250-6.
38. Brembeck FH, Schreiber FS, Deramaudt TB, et al. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. Cancer Res 2003;63:2005-9.
39. Shiotani A, Iishi H, Ishiguro S, et al. Epithelial cell turnover in relation to ongoing damage of the gastric mucosa in patients with early gastric cancer: increase of cell proliferation in paramalignant lesions. J Gastroenterol 2005;40:337-44.
40. Wyllie AH. The biology of cell death in tumors. Anticancer Res 1996;5:131-6.
41. Tanaka A, Watari J, Tanabe H, et al. Effect of eradication of Helicobacter pylori on genetic instabilities in gastric intestinal metaplasia. Aliment Pharmacol Ther symp ser 2006;2:194-202.